Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $1.357B (100.0% shares, 0.0% debt)

Holdings (31)

— MERUS N V 13.9%

Value $188M Shares 4,472,840 Est. Cost $30.24 Unrealized —

NUVL NUVALENT INC 9.7%

Value $132M Shares 1,855,000 Est. Cost $67.11 Unrealized +16.5%

ELVN ENLIVEN THERAPEUTICS INC 6.8%

Value $92M Shares 4,675,000 Est. Cost $19.08 Unrealized +12.8%

SLNO SOLENO THERAPEUTICS INC 6.1%

Value $82.17M Shares 1,150,000 Est. Cost $40.45 Unrealized +20.4%

XENE XENON PHARMACEUTICALS INC 5.7%

Value $78M Shares 2,325,000 Est. Cost $30.27 Unrealized +25.4%

ALKS ALKERMES PLC 4.7%

Value $64.39M Shares 1,950,000 Est. Cost $25.65 Unrealized +27.1%

AGIO AGIOS PHARMACEUTICALS INC 4.7%

Value $64.02M Shares 2,185,000 Est. Cost $33.17 Unrealized 0.0%

PCVX VAXCYTE INC 4.6%

Value $62.3M Shares 1,650,000 Est. Cost $73.54 Unrealized +8.7%

VERA VERA THERAPEUTICS INC 4.5%

Value $61.53M Shares 2,561,782 Est. Cost $13.95 Unrealized +130.3%

CLDX CELLDEX THERAPEUTICS INC NEW 4.3%

Value $58.08M Shares 3,200,000 Est. Cost $22.34 Unrealized 0.0%

SRRK SCHOLAR ROCK HLDG CORP 4.1%

Value $56.1M Shares 1,745,000 Est. Cost $35.25 Unrealized +9.1%

COGT COGENT BIOSCIENCES INC 3.9%

Value $53.27M Shares 8,892,816 Est. Cost $8.14 Unrealized -3.7%

VRDN VIRIDIAN THERAPEUTICS INC 3.6%

Value $48.53M Shares 3,600,000 Est. Cost $16.82 Unrealized +1.3%

NRIX NURIX THERAPEUTICS INC 3.5%

Value $47.27M Shares 3,978,907 Est. Cost $21.29 Unrealized -21.4%

CNTA CENTESSA PHARMACEUTICALS PLC 2.5%

Value $34.05M Shares 2,367,578 Est. Cost $16.17 Unrealized —

SYRE SPYRE THERAPEUTICS INC 2.4%

Value $32.08M Shares 1,988,084 Est. Cost $14.79 Unrealized +40.7%

PHVS PHARVARIS N V 2.2%

Value $30.01M Shares 1,911,433 Est. Cost $23.20 Unrealized -27.3%

— MIND MEDICINE MINDMED INC 2.0%

Value $26.47M Shares 4,525,000 Est. Cost $8.51 Unrealized —

SLDB SOLID BIOSCIENCES INC 1.6%

Value $21.55M Shares 5,825,000 Est. Cost $4.28 Unrealized 0.0%

DRUG BRIGHT MINDS BIOSCIENCES INC 1.3%

Value $18.04M Shares 500,000 Est. Cost $35.19 Unrealized +4.0%

CRDF CARDIFF ONCOLOGY INC 1.2%

Value $16.91M Shares 5,384,616 Est. Cost $3.13 Unrealized +26.5%

ORKA ORUKA THERAPEUTICS INC 1.1%

Value $14.57M Shares 1,419,714 Est. Cost $34.43 Unrealized -63.8%

IKT INHIBIKASE THERAPEUTICS INC 0.9%

Value $11.7M Shares 5,344,432 Est. Cost $2.49 Unrealized +0.7%

ORIC ORIC PHARMACEUTICALS INC 0.8%

Value $11.16M Shares 2,000,000 Est. Cost $11.88 Unrealized -26.4%

APGE APOGEE THERAPEUTICS INC 0.8%

Value $10.83M Shares 290,000 Est. Cost $25.01 Unrealized +54.6%

NGNE NEUROGENE INC 0.8%

Value $10.83M Shares 925,000 Est. Cost $33.71 Unrealized -48.5%

TYRA TYRA BIOSCIENCES INC 0.7%

Value $8.835M Shares 950,000 Est. Cost $12.94 Unrealized 0.0%

PCSC PERCEPTIVE CAP SOLUTIONS COR 0.6%

Value $7.725M Shares 750,000 Est. Cost $10.07 Unrealized +1.8%

CELC CELCUITY INC 0.5%

Value $7.033M Shares 695,650 Est. Cost $15.28 Unrealized -25.9%

VTGN VISTAGEN THERAPEUTICS INC 0.3%

Value $3.938M Shares 1,575,000 Est. Cost $4.44 Unrealized -36.3%

AVTX AVALO THERAPEUTICS INC 0.3%

Value $3.869M Shares 483,000 Est. Cost $10.53 Unrealized -28.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	4,472,840	$188M	13.9%	$30.24	—	COM	N5749R100
NUVL	NUVALENT INC	1,855,000	$132M	9.7%	$67.11	+16.5%	COM	670703107
ELVN	ENLIVEN THERAPEUTICS INC	4,675,000	$92M	6.8%	$19.08	+12.8%	COM	29337E102
SLNO	SOLENO THERAPEUTICS INC	1,150,000	$82.17M	6.1%	$40.45	+20.4%	COM	834203309
XENE	XENON PHARMACEUTICALS INC	2,325,000	$78M	5.7%	$30.27	+25.4%	COM	98420N105
ALKS	ALKERMES PLC	1,950,000	$64.39M	4.7%	$25.65	+27.1%	SHS	G01767105
AGIO	AGIOS PHARMACEUTICALS INC	2,185,000	$64.02M	4.7%	$33.17	0.0%	COM	00847X104
PCVX	VAXCYTE INC	1,650,000	$62.3M	4.6%	$73.54	+8.7%	COM	92243G108
VERA	VERA THERAPEUTICS INC	2,561,782	$61.53M	4.5%	$13.95	+130.3%	CL A	92337R101
CLDX	CELLDEX THERAPEUTICS INC NEW	3,200,000	$58.08M	4.3%	$22.34	0.0%	COM NEW	15117B202
SRRK	SCHOLAR ROCK HLDG CORP	1,745,000	$56.1M	4.1%	$35.25	+9.1%	COM	80706P103
COGT	COGENT BIOSCIENCES INC	8,892,816	$53.27M	3.9%	$8.14	-3.7%	COM	19240Q201
VRDN	VIRIDIAN THERAPEUTICS INC	3,600,000	$48.53M	3.6%	$16.82	+1.3%	COM	92790C104
NRIX	NURIX THERAPEUTICS INC	3,978,907	$47.27M	3.5%	$21.29	-21.4%	COM	67080M103
CNTA	CENTESSA PHARMACEUTICALS PLC	2,367,578	$34.05M	2.5%	$16.17	—	SPONSORED ADS	152309100
SYRE	SPYRE THERAPEUTICS INC	1,988,084	$32.08M	2.4%	$14.79	+40.7%	COM NEW	00773J202
PHVS	PHARVARIS N V	1,911,433	$30.01M	2.2%	$23.20	-27.3%	COM	N69605108
—	MIND MEDICINE MINDMED INC	4,525,000	$26.47M	2.0%	$8.51	—	COM NEW	60255C885
SLDB	SOLID BIOSCIENCES INC	5,825,000	$21.55M	1.6%	$4.28	0.0%	COM NEW	83422E204
DRUG	BRIGHT MINDS BIOSCIENCES INC	500,000	$18.04M	1.3%	$35.19	+4.0%	COM NEW	10919W405
CRDF	CARDIFF ONCOLOGY INC	5,384,616	$16.91M	1.2%	$3.13	+26.5%	COM	14147L108
ORKA	ORUKA THERAPEUTICS INC	1,419,714	$14.57M	1.1%	$34.43	-63.8%	COM	687604108
IKT	INHIBIKASE THERAPEUTICS INC	5,344,432	$11.7M	0.9%	$2.49	+0.7%	COM NEW	45719W205
ORIC	ORIC PHARMACEUTICALS INC	2,000,000	$11.16M	0.8%	$11.88	-26.4%	COM	68622P109
APGE	APOGEE THERAPEUTICS INC	290,000	$10.83M	0.8%	$25.01	+54.6%	COM	03770N101
NGNE	NEUROGENE INC	925,000	$10.83M	0.8%	$33.71	-48.5%	COM	64135M105
TYRA	TYRA BIOSCIENCES INC	950,000	$8.835M	0.7%	$12.94	0.0%	COM	90240B106
PCSC	PERCEPTIVE CAP SOLUTIONS COR	750,000	$7.725M	0.6%	$10.07	+1.8%	CL A ORD SHS	G70077105
CELC	CELCUITY INC	695,650	$7.033M	0.5%	$15.28	-25.9%	COM	15102K100
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$3.938M	0.3%	$4.44	-36.3%	COM	92840H400
AVTX	AVALO THERAPEUTICS INC	483,000	$3.869M	0.3%	$10.53	-28.0%	COM NEW	05338F306